Phase I Trial of Venetoclax in Combination With R-ICE (V+RICE) Chemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Venetoclax (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 17 Jul 2018 Planned primary completion date changed from 15 Nov 2018 to 21 Sep 2018.
- 17 Jul 2018 Status changed from recruiting to active, no longer recruiting.